The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, K. C.
Right arrow Articles by Coligan, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, K. C.
Right arrow Articles by Coligan, J. E.
Right arrowPubmed/NCBI databases
*Substance via MeSH

The Journal of Immunology, Vol 152, Issue 1 163-175, Copyright © 1994 by American Association of Immunologists

ARTICLES

Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains

KC Parker, MA Bednarek and JE Coligan
Biological Resources Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

A method to predict the relative binding strengths of all possible nonapeptides to the MHC class I molecule HLA-A2 has been developed based on experimental peptide binding data. These data indicate that, for most peptides, each side-chain of the peptide contributes a certain amount to the stability of the HLA-A2 complex that is independent of the sequence of the peptide. To quantify these contributions, the binding data from a set of 154 peptides were combined together to generate a table containing 180 coefficients (20 amino acids x 9 positions), each of which represents the contribution of one particular amino acid residue at a specified position within the peptide to binding to HLA-A2. Eighty peptides formed stable HLA-A2 complexes, as assessed by measuring the rate of dissociation of beta 2m. The remaining 74 peptides formed complexes that had a half-life of beta 2m dissociation of less than 5 min at 37 degrees C, or did not bind to HLA- A2, and were included because they could be used to constrain the values of some of the coefficients. The "theoretical" binding stability (calculated by multiplying together the corresponding coefficients) matched the experimental binding stability to within a factor of 5. The coefficients were then used to calculate the theoretical binding stability for all the previously identified self or antigenic nonamer peptides known to bind to HLA-A2. The binding stability for all other nonamer peptides that could be generated from the proteins from which these peptides were derived was also predicted. In every case, the previously described HLA-A2 binding peptides were ranked in the top 2% of all possible nonamers for each source protein. Therefore, most biologically relevant nonamer peptides should be identifiable using the table of coefficients. We conclude that the side-chains of most nonamer peptides to the first approximation bind independently of one another to the HLA-A2 molecule.


This article has been cited by other articles:


Home page
 BioinformaticsHome page
Y. Xiao and M. R. Segal
Biological sequence classification utilizing positive and unlabeled data
Bioinformatics, May 1, 2008; 24(9): 1198 - 1205.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. Feldhahn, P. Thiel, M. M. Schuler, N. Hillen, S. Stevanovic, H.-G. Rammensee, and O. Kohlbacher
EpiToolKit--a web server for computational immunomics
Nucleic Acids Res., April 24, 2008; (2008) gkn229v1.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. Aoshi, T. Nagata, M. Suzuki, M. Uchijima, D. Hashimoto, A. Rafiei, T. Suda, K. Chida, and Y. Koide
Identification of an HLA-A*0201-Restricted T-Cell Epitope on the MPT51 Protein, a Major Secreted Protein Derived from Mycobacterium tuberculosis, by MPT51 Overlapping Peptide Screening
Infect. Immun., April 1, 2008; 76(4): 1565 - 1571.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. M. Truscott, X. Wang, L. Lybarger, W. E. Biddison, C. McBerry, J. M. Martinko, J. M. Connolly, G. P. Linette, D. H. Fremont, T. H. Hansen, et al.
Human Major Histocompatibility Complex (MHC) Class I Molecules with Disulfide Traps Secure Disease-related Antigenic Peptides and Exclude Competitor Peptides
J. Biol. Chem., March 21, 2008; 283(12): 7480 - 7490.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
G. Turk, M. M. Gherardi, N. Laufer, M. Saracco, R. Luzzi, J. H. Cox, P. Cahn, and H. Salomon
Magnitude, Breadth, and Functional Profile of T-Cell Responses during Human Immunodeficiency Virus Primary Infection with B and BF Viral Variants
J. Virol., March 15, 2008; 82(6): 2853 - 2866.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Kawase, Y. Nannya, H. Torikai, G. Yamamoto, M. Onizuka, S. Morishima, K. Tsujimura, K. Miyamura, Y. Kodera, Y. Morishima, et al.
Identification of human minor histocompatibility antigens based on genetic association with highly parallel genotyping of pooled DNA
Blood, March 15, 2008; 111(6): 3286 - 3294.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. de la Luz Garcia-Hernandez, A. Gray, B. Hubby, O. J. Klinger, and W. M. Kast
Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity
Cancer Res., February 1, 2008; 68(3): 861 - 869.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. H. Segal, D. W. Parsons, K. S. Peggs, V. Velculescu, K. W. Kinzler, B. Vogelstein, and J. P. Allison
Epitope Landscape in Breast and Colorectal Cancer
Cancer Res., February 1, 2008; 68(3): 889 - 892.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. E. Peoples, J. P. Holmes, M. T. Hueman, E. A. Mittendorf, A. Amin, S. Khoo, Z. A. Dehqanzada, J. M. Gurney, M. M. Woll, G. B. Ryan, et al.
Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02
Clin. Cancer Res., February 1, 2008; 14(3): 797 - 803.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Shi, G. J. Tricot, T. K. Garg, P. A. Malaviarachchi, S. M. Szmania, R. E. Kellum, B. Storrie, A. Mulder, J. D. Shaughnessy Jr, B. Barlogie, et al.
Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma
Blood, February 1, 2008; 111(3): 1309 - 1317.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Guihot, E. Oksenhendler, L. Galicier, A.-G. Marcelin, L. Papagno, A.-S. Bedin, F. Agbalika, N. Dupin, J. Cadranel, B. Autran, et al.
Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells
Blood, February 1, 2008; 111(3): 1387 - 1395.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. A. Chentoufi, X. Zhang, K. Lamberth, G. Dasgupta, I. Bettahi, A. Nguyen, M. Wu, X. Zhu, A. Mohebbi, S. Buus, et al.
HLA-A*0201-Restricted CD8+ Cytotoxic T Lymphocyte Epitopes Identified from Herpes Simplex Virus Glycoprotein D
J. Immunol., January 1, 2008; 180(1): 426 - 437.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Vallbracht, B. Jessen, S. Mrusek, A. Enders, P. L. Collins, S. Ehl, and C. D. Krempl
Influence of a Single Viral Epitope on T Cell Response and Disease After Infection of Mice with Respiratory Syncytial Virus
J. Immunol., December 15, 2007; 179(12): 8264 - 8273.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
C. Lundegaard, O. Lund, C. Kesmir, S. Brunak, and M. Nielsen
Modeling the adaptive immune system: predictions and simulations
Bioinformatics, December 15, 2007; 23(24): 3265 - 3275.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. T. Mars, J. Bauer, D. A. Gross, F. Bucciarelli, H. Firat, D. Hudrisier, F. Lemonnier, K. Kosmatopoulos, and R. S. Liblau
CD8 T Cell Responses to Myelin Oligodendrocyte Glycoprotein-Derived Peptides in Humanized HLA-A*0201-Transgenic Mice
J. Immunol., October 15, 2007; 179(8): 5090 - 5098.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
I. G. Schuster, D. H. Busch, E. Eppinger, E. Kremmer, S. Milosevic, C. Hennard, C. Kuttler, J. W. Ellwart, B. Frankenberger, E. Nossner, et al.
Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies
Blood, October 15, 2007; 110(8): 2931 - 2939.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Wolfl, J. Kuball, W. Y. Ho, H. Nguyen, T. J. Manley, M. Bleakley, and P. D. Greenberg
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities
Blood, July 1, 2007; 110(1): 201 - 210.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Mancini-Bourgine, F. Bayard, P. Soussan, Q. Deng, Y.-C. Lone, D. Kremsdorf, and M.-L. Michel
Hepatitis B Virus Splice-Generated Protein Induces T-Cell Responses in HLA-Transgenic Mice and Hepatitis B Virus-Infected Patients
J. Virol., May 15, 2007; 81(10): 4963 - 4972.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Palena, D. E. Polev, K. Y. Tsang, R. I. Fernando, M. Litzinger, L. L. Krukovskaya, A. V. Baranova, A. P. Kozlov, and J. Schlom
The Human T-Box Mesodermal Transcription Factor Brachyury Is a Candidate Target for T-Cell-Mediated Cancer Immunotherapy
Clin. Cancer Res., April 15, 2007; 13(8): 2471 - 2478.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
M. G. Chaitra, M. S. Shaila, and R. Nayak
Evaluation of T-cell responses to peptides with MHC class I-binding motifs derived from PE_PGRS 33 protein of Mycobacterium tuberculosis
J. Med. Microbiol., April 1, 2007; 56(4): 466 - 474.
[Abstract] [Full Text] [PDF]

Home page
 Brief BioinformHome page
J. C. Tong, T. W. Tan, and S. Ranganathan
Methods and protocols for prediction of immunogenic epitopes
Brief Bioinform, March 1, 2007; 8(2): 96 - 108.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Lee, S. A. Miller, D. W. Wright, M. T. Rock, and J. E. Crowe Jr.
Tissue-Specific Regulation of CD8+ T-Lymphocyte Immunodominance in Respiratory Syncytial Virus Infection
J. Virol., March 1, 2007; 81(5): 2349 - 2358.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Nava-Parada, G. Forni, K. L. Knutson, L. R. Pease, and E. Celis
Peptide Vaccine Given with a Toll-Like Receptor Agonist Is Effective for the Treatment and Prevention of Spontaneous Breast Tumors
Cancer Res., February 1, 2007; 67(3): 1326 - 1334.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. d. l. L. Garcia-Hernandez, A. Gray, B. Hubby, and W. M. Kast
In vivo Effects of Vaccination with Six-Transmembrane Epithelial Antigen of the Prostate: A Candidate Antigen for Treating Prostate Cancer
Cancer Res., February 1, 2007; 67(3): 1344 - 1351.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
X. Cortez-Gonzalez, J. Sidney, O. Adotevi, A. Sette, F. Millard, F. Lemonnier, P. Langlade-Demoyen, and M. Zanetti
Immunogenic HLA-B7-restricted peptides of hTRT
Int. Immunol., December 1, 2006; 18(12): 1707 - 1718.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
S. T. Chang, D. Ghosh, D. E. Kirschner, and J. J. Linderman
Peptide length-based prediction of peptide-MHC class II binding
Bioinformatics, November 15, 2006; 22(22): 2761 - 2767.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. E. Standifer, Q. Ouyang, C. Panagiotopoulos, C. B. Verchere, R. Tan, C. J. Greenbaum, C. Pihoker, and G. T. Nepom
Identification of Novel HLA-A*0201-Restricted Epitopes in Recent-Onset Type 1 Diabetic Subjects and Antibody-Positive Relatives
Diabetes, November 1, 2006; 55(11): 3061 - 3067.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Q. Ouyang, N. E. Standifer, H. Qin, P. Gottlieb, C. B. Verchere, G. T. Nepom, R. Tan, and C. Panagiotopoulos
Recognition of HLA Class I-Restricted {beta}-Cell Epitopes in Type 1 Diabetes
Diabetes, November 1, 2006; 55(11): 3068 - 3074.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Hirano, M. O. Butler, Z. Xia, A. Berezovskaya, A. P. Murray, S. Ansen, S. Kojima, and L. M. Nadler
Identification of an immunogenic CD8+ T-cell epitope derived from {gamma}-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia
Blood, October 15, 2006; 108(8): 2662 - 2668.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Ishizaki, T. Tsunoda, S. Wada, M. Yamauchi, M. Shibuya, and H. Tahara
Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1.
Clin. Cancer Res., October 1, 2006; 12(19): 5841 - 5849.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Zhou, D. Xu, X. Li, H. Li, M. Shan, J. Tang, M. Wang, F.-S. Wang, X. Zhu, H. Tao, et al.
Screening and Identification of Severe Acute Respiratory Syndrome-Associated Coronavirus-Specific CTL Epitopes
J. Immunol., August 15, 2006; 177(4): 2138 - 2145.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. C. Tscharke, W.-P. Woo, I. G. Sakala, J. Sidney, A. Sette, D. J. Moss, J. R. Bennink, G. Karupiah, and J. W. Yewdell
Poxvirus CD8+ T-Cell Determinants and Cross-Reactivity in BALB/c Mice.
J. Virol., July 1, 2006; 80(13): 6318 - 6323.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Wang, J. Epler, L. G. Salazar, and S. R. Riddell
Recognition of Breast Cancer Cells by CD8+ Cytotoxic T-Cell Clones Specific for NY-BR-1.
Cancer Res., July 1, 2006; 66(13): 6826 - 6833.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
P. Donnes and O. Kohlbacher
SVMHC: a server for prediction of MHC-binding peptides.
Nucleic Acids Res., July 1, 2006; 34(Web Server issue): W194 - W197.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
S. Zhu, K. Udaka, J. Sidney, A. Sette, K. F. Aoki-Kinoshita, and H. Mamitsuka
Improving MHC binding peptide prediction by incorporating binding data of auxiliary MHC molecules
Bioinformatics, July 1, 2006; 22(13): 1648 - 1655.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Fukuyama, T. Hanagiri, M. Takenoyama, Y. Ichiki, M. Mizukami, T. So, M. Sugaya, T. So, K. Sugio, and K. Yasumoto
Identification of a New Cancer/Germline Gene, KK-LC-1, Encoding an Antigen Recognized by Autologous CTL Induced on Human Lung Adenocarcinoma.
Cancer Res., May 1, 2006; 66(9): 4922 - 4928.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Y. Chen, J. Trofe, J. Gordon, R. A. Du Pasquier, P. Roy-Chaudhury, M. J. Kuroda, E. S. Woodle, K. Khalili, and I. J. Koralnik
Interplay of Cellular and Humoral Immune Responses against BK Virus in Kidney Transplant Recipients with Polyomavirus Nephropathy.
J. Virol., April 1, 2006; 80(7): 3495 - 3505.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Samino, D. Lopez, S. Guil, L. Saveanu, P. M. van Endert, and M. Del Val
A Long N-terminal-extended Nested Set of Abundant and Antigenic Major Histocompatibility Complex Class I Natural Ligands from HIV Envelope Protein
J. Biol. Chem., March 10, 2006; 281(10): 6358 - 6365.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. W. Rohrer, A. L. Barsoum, and J. H. Coggin Jr.
Identification of Oncofetal Antigen/Immature Laminin Receptor Protein Epitopes That Activate BALB/c Mouse OFA/iLRP-Specific Effector and Regulatory T Cell Clones.
J. Immunol., March 1, 2006; 176(5): 2844 - 2856.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
E. Milner, E. Barnea, I. Beer, and A. Admon
The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer Cells
Mol. Cell. Proteomics, February 1, 2006; 5(2): 357 - 365.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Ribechini, C. Fortini, M. Marastoni, S. Traniello, S. Spisani, P. Monini, and R. Gavioli
Identification of CD8+ T Cell Epitopes within Lytic Antigens of Human Herpes Virus 8
J. Immunol., January 15, 2006; 176(2): 923 - 930.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Niland, K. Banki, W. E. Biddison, and A. Perl
CD8+ T Cell-Mediated HLA-A*0201-Restricted Cytotoxicity to Transaldolase Peptide 168-176 in Patients with Multiple Sclerosis
J. Immunol., December 15, 2005; 175(12): 8365 - 8378.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
S. Hofmann, M. Gluckmann, S. Kausche, A. Schmidt, C. Corvey, R. Lichtenfels, C. Huber, C. Albrecht, M. Karas, and W. Herr
Rapid and Sensitive Identification of Major Histocompatibility Complex Class I-associated Tumor Peptides by Nano-LC MALDI MS/MS
Mol. Cell. Proteomics, December 1, 2005; 4(12): 1888 - 1897.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Jing, T. M. Chong, C. L. McClurkan, J. Huang, B. T. Story, and D. M. Koelle
Diversity in the Acute CD8 T Cell Response to Vaccinia Virus in Humans
J. Immunol., December 1, 2005; 175(11): 7550 - 7559.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. A. W. Claassen, P. A. A. van der Kant, Z. S. Rychnavska, G. M. van Bleek, A. J. Easton, and R. G. van der Most
Activation and Inactivation of Antiviral CD8 T Cell Responses during Murine Pneumovirus Infection
J. Immunol., November 15, 2005; 175(10): 6597 - 6604.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. B. Batchu, A. M. Moreno, S. M. Szmania, G. Bennett, G. C. Spagnoli, S. Ponnazhagan, B. Barlogie, G. Tricot, and F. van Rhee
Protein Transduction of Dendritic Cells for NY-ESO-1-Based Immunotherapy of Myeloma
Cancer Res., November 1, 2005; 65(21): 10041 - 10049.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Maia, W. N. Haining, S. Ansen, Z. Xia, S. A. Armstrong, N. P. Seth, P. Ghia, M. L. den Boer, R. Pieters, S. E. Sallan, et al.
Gene Expression Profiling Identifies BAX-{delta} as a Novel Tumor Antigen in Acute Lymphoblastic Leukemia
Cancer Res., November 1, 2005; 65(21): 10050 - 10058.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
P. Correale, M. T. Del Vecchio, G. Di Genova, G. G. Savellini, M. La Placa, C. Terrosi, M. Vestri, R. Urso, F. Lemonnier, A. Aquino, et al.
5-Fluorouracil-Based Chemotherapy Enhances the Antitumor Activity of a Thymidylate Synthase-Directed Polyepitopic Peptide Vaccine
J Natl Cancer Inst, October 5, 2005; 97(19): 1437 - 1445.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
A. Boesen, K. Sundar, and R. Coico
Lassa Fever Virus Peptides Predicted by Computational Analysis Induce Epitope-Specific Cytotoxic-T-Lymphocyte Responses in HLA-A2.1 Transgenic Mice
Clin. Vaccine Immunol., October 1, 2005; 12(10): 1223 - 1230.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Matsueda, H. Takedatsu, A. Yao, M. Tanaka, M. Noguchi, K. Itoh, and M. Harada
Identification of Peptide Vaccine Candidates for Prostate Cancer Patients with HLA-A3 Supertype Alleles
Clin. Cancer Res., October 1, 2005; 11(19): 6933 - 6943.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Yokokawa, C. Palena, P. Arlen, R. Hassan, M. Ho, I. Pastan, J. Schlom, and K. Y. Tsang
Identification of Novel Human CTL Epitopes and Their Agonist Epitopes of Mesothelin
Clin. Cancer Res., September 1, 2005; 11(17): 6342 - 6351.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Radvanyi, D. Singh-Sandhu, S. Gallichan, C. Lovitt, A. Pedyczak, G. Mallo, K. Gish, K. Kwok, W. Hanna, J. Zubovits, et al.
The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer
PNAS, August 2, 2005; 102(31): 11005 - 11010.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
N. Harashima, R. Tanosaki, Y. Shimizu, K. Kurihara, T. Masuda, J. Okamura, and M. Kannagi
Identification of Two New HLA-A*1101-Restricted Tax Epitopes Recognized by Cytotoxic T Lymphocytes in an Adult T-Cell Leukemia Patient after Hematopoietic Stem Cell Transplantation
J. Virol., August 1, 2005; 79(15): 10088 - 10092.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
P. Donnes and O. Kohlbacher
Integrated modeling of the major events in the MHC class I antigen processing pathway
Protein Sci., August 1, 2005; 14(8): 2132 - 2140.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. E. Clark and R. H. Vonderheide
Getting to the Surface: A Link Between Tumor Antigen Discovery and Natural Presentation of Peptide-MHC Complexes
Clin. Cancer Res., August 1, 2005; 11(15): 5333 - 5336.
[Full Text] [PDF]

Home page
 BloodHome page
J. Greiner, L. Li, M. Ringhoffer, T. F. E. Barth, K. Giannopoulos, P. Guillaume, G. Ritter, M. Wiesneth, H. Dohner, and M. Schmitt
Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia
Blood, August 1, 2005; 106(3): 938 - 945.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Correale*, M. G. Cusi, M. T. Del Vecchio, A. Aquino, S. Prete, K. Y. Tsang, L. Micheli, C. Nencini, M. La Placa*, F. Montagnani*, et al.
Dendritic Cell-Mediated Cross-Presentation of Antigens Derived from Colon Carcinoma Cells Exposed to a Highly Cytotoxic Multidrug Regimen with Gemcitabine, Oxaliplatin, 5-Fluorouracil, and Leucovorin, Elicits a Powerful Human Antigen-Specific CTL Response with Antitumor Activity in Vitro
J. Immunol., July 15, 2005; 175(2): 820 - 828.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Lotz, S. A. Mutallib, N. Oehlrich, U. Liewer, E. A. Ferreira, M. Moos, M. Hundemer, S. Schneider, S. Strand, C. Huber, et al.
Targeting Positive Regulatory Domain I-Binding Factor 1 and X Box-Binding Protein 1 Transcription Factors by Multiple Myeloma-Reactive CTL
J. Immunol., July 15, 2005; 175(2): 1301 - 1309.
[Abstract] [Full Text] [PDF]

Home page